1 The goal of this study was to analyse the effects of propafenone and
its major metabolite, 5-hydroxy-propafenone, on a human cardiac K+ ch
annel (hKv1.5) stably expressed in Ltk(-) cells and using the whole-ce
ll configuration of the patch-clamp technique. 2 Propafenone and 5-hyd
roxy-propafenone inhibited in a concentration-dependent manner the hKv
1.5 current with KD values of 4.4+/-0.3 mu M and 9.2+/-1.6 mu M, respe
ctively. 3 Block induced by both drugs was voltage-dependent consisten
t with a value of electrical distance (referenced to the cytoplasmic s
ide) of 0.17+/-0.55 (n=10) and 0.16+/-0.81 (n=16). 4 The apparent asso
ciation (k) and dissociation (I) rate constants for propafenone were (
8.9+/-0.9) x 10(6) M-1 s(-1) and 39.5+/-4.2 s(-1), respectively. For 5
-hydroxy-propafenone these values averaged (2.3+/-0.3) x 10(6) M-1 s(-
1) and 21.4+/-3.1 s(-1), respectively. 5 Both drugs reduced the tail c
urrent amplitude recorded at -40 mV after 250 ms depolarizing pulses t
o + 60 mV, and slowed the deactivation time course resulting in a 'cro
ssover' phenomenon when the tail currents recorded under control condi
tions and in the presence of each drug were superimposed. 6 Both compo
unds induced a small but statistically significant use-dependent block
when trains of depolarizations at frequencies between 0.5 and 3 Hz we
re applied. 7 These results indicate that propafenone and its metaboli
te block hKv1.5 channels in a concentration-, voltage-, time- and use-
dependent manner and the concentrations needed to observe these effect
s are in the therapeutical range.